Alcohol
Volume 35, Issue 3 , Pages 195-203 , April 2005

Alcohol and liver cancer

Received 11 February 2005 ,Revised 20 April 2005 ,Accepted 20 April 2005.

References 

  1. Aguayo A, Patt YZ. Liver cancer. Clin Liver Dis. 2001;5:479–507
  2. Albano E, French SW, Ingelman-Sundberg M. Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci. 1999;4:D533–D540
  3. Aroor AR, Shukla SD. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004;74:2339–2364
  4. Bai J, Cederbaum AI. Mitochondrial catalase and oxidative injury. Biol Signals Recept. 2001;10:189–199
  5. Bauer I, Bauer M, Pannen BH, Leinwand MJ, Zhang JX, Clemens MG. Chronic ethanol consumption exacerbates liver injury following hemorrhagic shock: role of sinusoidal perfusion failure. Shock. 1995;4:324–331
  6. Bhatia N, Zhao J, Wolf DM, Agarwal R. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Cancer Lett. 1999;147:77–84
  7. Bhattacharya R, Shuhart MC. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol. 2003;36:242–252
  8. Bocckino SB, Wilson PB, Exton JH. Ca2+-mobilizing hormones elicit phosphatidylethanol accumulation via phospholipase D activation. FEBS Lett. 1987;225:201–204
  9. Bode C, Bode JC. Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol. 2003;17:575–592
  10. Booyse FM, Parks DA. Moderate wine and alcohol consumption: beneficial effects on cardiovascular disease. Thromb Haemost. 2001;86:517–528
  11. Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol. 1982;11:112–119
  12. Campos R, Garrido A, Guerra R, Valenzuela A. Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta Med. 1989;55:417–419
  13. Casey CA, Nanji A, Cederbaum AI, Adachi M, Takahashi T. Alcoholic liver disease and apoptosis. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA):49S–53S
  14. Chandra S, Gonzalez de Mejia E. Polyphenolic compounds, antioxidant capacity, and quinone reductase activity of an aqueous extract of Ardisia compressa in comparison to mate (Ilex paraguariensis) and green (Camellia sinensis) teas. J Agric Food Chem. 2004;52:3583–3589
  15. Chen J, Bao H, Sawyer S, Kunos G, Gao B. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun. 1997;239:666–669
  16. Chen J, Clemens DL, Cederbaum AI, Gao B. Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin Biochem. 2001;34:203–209
  17. Chen J, Ishac EJN, Dent P, Kunos G, Gao B. Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. Biochem J. 1998;334:669–676
  18. Comoglio A, Tomasi A, Malandrino S, Poli G, Albano E. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals. Biochem Pharmacol. 1995;50:1313–1316
  19. Crabb DW, Bosron WF, Li T-K. Ethanol metabolism. Pharmacol Ther. 1987;34:59–73
  20. de Groot H, Dehmlow C, Raven U. Tissue injury by free radicals and the protective effects of flavonoids. Methods Find Exp Clin Pharmacol. 1996;18(Suppl B):23–25
  21. DePetrillo PB, Liou CS. Ethanol exposure increases total protein kinase C activity in human lymphocytes. Alcohol Clin Exp Res. 1993;17:351–354
  22. Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. Silibinin inhibits constitutive and TNFα-induced activation of NF-κB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis. Oncogene. 2002;21:1759–1767
  23. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma. Ann Intern Med. 1988;108:390–401
  24. Diehl AM. Recent events in alcoholic liver disease. V. Effects of ethanol on liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1–G6
  25. Diehl AM, Rai RM. Liver regeneration 3: regulation of signal transduction during liver regeneration. FASEB J. 1996;10:215–227
  26. Diehl AM, Yang SQ, Cote P, Wand GS. Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP-dependent signaling in regenerating rat liver. Hepatology. 1992;16:1212–1219
  27. Diehl AM, Yang SQ, Wolfgang D, Wand G. Differential expression of guanine nucleotide–binding proteins enhances cAMP synthesis in regenerating rat liver. J Clin Invest. 1992;89:1706–1712
  28. Djordjevic D, Nikolic J, Stefanovic V. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens. Pathol Biol (Paris). 1998;46:760–770
  29. Donohue TM, Clemens DL, Galli A, Crabb D, Nieto N, Kato J, et al. Use of cultured cells in assessing ethanol toxicity and ethanol-related metabolism. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA):87S–93S
  30. Dreosti IE, Ballard FJ, Belling GB, Record IR, Manuel SJ, Hetzel BS. The effect of ethanol and acetaldehyde on DNA synthesis in growing cells and on fetal development in the rat. Alcohol Clin Exp Res. 1981;5:357–362
  31. Dupont I, Lucas D, Clot P, Menez C, Albano E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatol. 1998;28:564–571
  32. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol. 1989;38:1313–1319
  33. el-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001;5:87–107vi
  34. Fataccioli V, Andraud E, Gentil M, French SW, Rouach H. Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. Hepatology. 1999;29:14–20
  35. Feher J, Lang I, Nekam K, Gergely P, Muzes G. In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients. Tokai J Exp Clin Med. 1990;15:129–134
  36. Fernández-Checa JC, Colell A, García-Ruiz C. S-Adenosyl-l-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease. Alcohol. 2002;27:179–183
  37. Fernández-Checa JC, Kaplowitz N, García-Ruiz C, Colell A. Mitochondrial glutathione: importance and transport. Semin Liver Dis. 1998;18:389–401
  38. Fiorentini G, Poddie DB, Cantore M, Giovanis P, Guadagni S, De Giorgi U, et al. Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepatogastroenterology. 2001;48:305–312
  39. García-Ruiz C, Morales A, Colell A, Ballesta A, Rodes J, Kaplowitz N, et al. Feeding S-adenosyl-l-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology. 1995;21:207–214
  40. García-Trevijano ER, Iraburu MJ, Fontana L, Domínguez-Rosales JA, Auster A, Covarrubias-Pinedo A, et al. Transforming growth factor β1 induces the expression of α1(I) procollagen mRNA by a hydrogen peroxide-C/EBPβ-dependent mechanism in rat hepatic stellate cells. Hepatology. 1999;29:960–970
  41. Gill JS. Reported levels of alcohol consumption and binge drinking within the UK undergraduate student population over the last 25 years. Alcohol Alcohol. 2002;37:109–120
  42. Guengerich FP, Shimada T, Yun CH, Yamazaki H, Raney KD, Thier R, et al. Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environ Health Perspect. 1994;102(Suppl 9):49–53
  43. Hakova H, Misurova E. Therapeutical effect of silymarin on nucleic acids in the various organs of rats after radiation injury. Radiats Biol Radioecol. 1996;36:365–370
  44. Halim AB, el-Ahmady O, Hassab-Allah S, Abdel-Galil F, Hafez Y, Darwish A. Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage. Ann Clin Biochem. 1997;34(Pt 6):656–663
  45. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol. 2002;27:63–68
  46. Hoek JB, Thomas AP, Rooney TA, Higashi K, Rubin E. Ethanol and signal transduction in the liver. FASEB J. 1992;6:2386–2396
  47. Hoffman PL, Tabakoff B. Ethanol and guanine nucleotide binding proteins: a selective interaction. FASEB J. 1990;4:2612–2622
  48. Holmes-McNary M. Impact factors on development of cirrhosis and subsequent hepatocellular carcinoma. Compend Contin Educ Dent. 2001;22:19–33
  49. Huynh H, Nguyen TTT, Chow K-HP, Tan PH, Soo KC, Tran E. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol. 2003;3:19
  50. Ido K, Isoda N, Sugano K. Microwave coagulation therapy for liver cancer: laparoscopic microwave coagulation. J Gastroenterol. 2001;36:145–152
  51. Jimenez-Lopez JM, Cederbaum AI. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity. Free Radic Biol Med. 2004;36:359–370
  52. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA. Liver regeneration. J Am Coll Surg. 2003;197:634–659
  53. Kopp MU, Winterhalter KH, Trueb B. DNA methylation accounts for the inhibition of collagen VI expression in transformed fibroblasts. Eur J Biochem. 1997;249:489–496
  54. Koteish A, Yang S, Lin H, Huang X, Diehl AM. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J Biol Chem. 2002;277:13037–13044
  55. Kruger H, Wilce PA, Shanley BC. Ethanol and protein kinase C in rat brain. Neurochem Int. 1993;22:575–581
  56. Kuper H, Tzonou A, Lagiou P, Mucci LA, Trichopoulos D, Stuver SO, et al. Diet and hepatocellular carcinoma: a case-control study in Greece. Nutr Cancer. 2000;38:6–12
  57. Kushnareva Y, Murphy AN, Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation–reduction state. Biochem J. 2002;368:545–553
  58. Lee YJ, Aroor AR, Shukla SD. Temporal activation of p42/44 mitogen-activated protein kinase and c-Jun N-terminal kinase by acetaldehyde in rat hepatocytes and its loss after chronic ethanol exposure. J Pharmacol Exp Ther. 2002;301:908–914
  59. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life. 2001;52:159–164
  60. Lieber CS. Biochemical mechanisms of alcohol-induced hepatic injury. Alcohol Alcohol Suppl. 1991;1:283–290
  61. Lieber CS. Alcohol: its metabolism and interaction with nutrients. Annu Rev Nutr. 2000;20:395–430
  62. Lieber CS. S-Adenosyl-l-methionine: its role in the treatment of liver disorders. Am J Clin Nutr. 2002;76(suppl):1183S–1187S
  63. Lieber CS, Leo MA. Metabolism of ethanol and some associated adverse effects on the liver and the stomach. Recent Dev Alcohol. 1998;14:7–40
  64. Longnecker MP. Alcohol consumption and risk of cancer in humans: an overview. Alcohol. 1995;12:87–96
  65. Lu SC. Regulation of glutathione synthesis. Curr Top Cell Regul. 2000;36:95–116
  66. Lu SC. S-Adenosylmethionine. Int J Biochem Cell Biol. 2000;32:391–395
  67. Lu SC, Alvarez L, Huang Z-Z, Chen L, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A. 2001;98:5560–5565
  68. Macdonald GA. Pathogenesis of hepatocellular carcinoma. Clin Liver Dis. 2001;5:69–85
  69. Magliulo E, Carosi PG, Minoli L, Gorini S. Studies on the regenerative capacity of the liver in rats subjected to partial hepatectomy and treated with silymarin. Arzneimittelforschung. 1973;23(Suppl):161–167
  70. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest. 1990;86:1641–1648
  71. Mangnall D, Bird NC, Majeed AW. The molecular physiology of liver regeneration following partial hepatectomy. Liver Int. 2003;23:124–138
  72. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther. 1997;73:265–280
  73. Mato JM, Corrales FJ, Lu SC, Avila MA. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J. 2002;16:15–26
  74. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2004;287:G497–G502
  75. McKillop IH, Schmidt CM, Cahill PA, Sitzmann JV. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology. 1997;26:1484–1491
  76. McKillop IH, Schmidt CM, Cahill PA, Sitzmann JV. Inhibitory guanine nucleotide regulatory protein activation of mitogen-activated protein kinase in experimental hepatocellular carcinoma in vitro. Eur J Gastroenterol Hepatol. 1999;11:761–768
  77. McKillop IH, Vyas N, Schmidt CM, Cahill PA, Sitzmann JV. Enhanced Gi-protein–mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma. Hepatology. 1999;29:412–420
  78. McKillop IH, Wu Y, Cahill PA, Sitzmann JV. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma. J Cell Physiol. 1998;175:295–304
  79. Mereish KA, Bunner DL, Ragland DR, Creasia DA. Protection against microcystin-LR-induced hepatotoxicity by Silymarin: biochemistry, histopathology, and lethality. Pharm Res. 1991;8:273–277
  80. Miura D, Miura Y, Yagasaki K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 2003;73:1393–1400
  81. Morimoto M, Hagbjork AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, et al. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol. 1993;10:459–464
  82. Moroz P, Jones SK, Gray BN. Status of hyperthermia in the treatment of advanced liver cancer. J Surg Oncol. 2001;77:259–269
  83. Muller A, Machnik F, Zimmermann T, Schubert H. Thioacetamide-induced cirrhosis-like liver lesions in rats—usefulness and reliability of this animal model. Exp Pathol. 1988;34:229–236
  84. Muriel P, Castro V. Effects of S-adenosyl-l-methionine and interferon-α2b on liver damage induced by bile duct ligation in rats. J Appl Toxicol. 1998;18:143–147
  85. Nanji AA, French SW. Hepatocellular carcinoma. Relationship to wine and pork consumption. Cancer. 1985;56:2711–2712
  86. Okuda K. Hepatocellular carcinoma—history, current status and perspectives. Dig Liver Dis. 2002;34:613–616
  87. Pandey SC. Acute and chronic ethanol consumption effects on the immunolabeling of Gq/11α subunit protein and phospholipase C isozymes in the rat brain. J Neurochem. 1996;67:2355–2361
  88. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–543
  89. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ. 1984;62:163–182
  90. Pascale RM, Simile MM, Seddaiu MA, Daino L, Vinci MA, Pinna G, et al. Chemoprevention of rat liver carcinogenesis by S-adenosyl-l-methionine: is DNA methylation involved?. Basic Life Sci. 1993;61:219–237
  91. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000;21:49–98
  92. Qin G, Gopalan-Kriczky P, Su J, Ning Y, Lotlikar PD. Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett. 1997;112:149–154
  93. Rambaldi A, Gluud C. S-adenosyl-l-methionine for alcoholic liver diseases. Cochrane Database Syst Rev. 2001;CD002235
  94. Reddy MA, Shukla SD. Potentiation of mitogen-activated protein kinase by ethanol in embryonic liver cells. Biochem Pharmacol. 1996;51:661–668
  95. Rhodes K, Breindl M. Developmental changes in the methylation status of regulatory elements in the murine alpha 1(I) collagen gene. Gene Expr. 1992;2:59–69
  96. Roivainen R, Hundle B, Messing RO. Protein kinase C and adaptation to ethanol. EXS. 1994;71:29–38
  97. Rojkind M, Rojkind MH, Cordero-Hernandez J. In vivo collagen synthesis and deposition in fibrotic and regenerating rat livers. Coll Relat Res. 1983;3:335–347
  98. Romeo R, Colombo M. The natural history of hepatocellular carcinoma. Toxicology. 2002;181–182:39–42
  99. Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct. 2003;28:105–112
  100. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma. Hepatology. 1997;26:1189–1194
  101. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun. 1997;236:54–58
  102. Senoo H. Structure and function of hepatic stellate cells. Med Electron Microsc. 2004;37:3–15
  103. Shaw S, Eng J, Jayatilleke E. Ethanol-induced free radical injury to the hepatocyte glucagon receptor. Alcohol. 1995;12:273–277
  104. Shibata A, Hirohata T, Toshima H, Tashiro H. The role of drinking and cigarette smoking in the excess deaths from liver cancer. Jpn J Cancer Res. 1986;77:287–295
  105. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL. Global and regional estimates of cancer mortality and incidence by site. II. Results for the global burden of disease 2000. BMC Cancer. 2002;2:37
  106. Singh RP, Tyagi AK, Zhao J, Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis. 2002;23:499–510
  107. Sitzmann JV, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg. 1993;217:149–154
  108. Sun AY, Ingelman-Sundberg M, Neve E, Matsumoto H, Nishitani Y, Minowa Y, et al. Ethanol and oxidative stress. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA):237S–243S
  109. Szilard S, Szentgyorgyi D, Demeter I. Protective effect of Legalon in workers exposed to organic solvents. Acta Med Hung. 1988;45:249–256
  110. Thompson JP, Simkevich CP, Holness MA, Kang AH, Raghow R. In vitro methylation of the promoter and enhancer of Proα1(I) collagen gene leads to its transcriptional inactivation. J Biol Chem. 1991;266:2549–2556
  111. Thurman RG. Mechanisms of hepatic toxicity. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol Gastrointest Liver Physiol. 1998;275:G605–G611
  112. Thurman RG, Bradford BU, Iimuro Y, Frankenberg MV, Knecht KT, Connor HD, et al. Mechanisms of alcohol-induced hepatotoxicity: studies in rats. Front Biosci. 1999;4:e42–e46
  113. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, et al. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J. 1998;330:1451–1460
  114. Tsukamoto H, Towner SJ, Ciofalo LM, French SW. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology. 1986;6:814–822
  115. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005;9:151–169
  116. Vollmar B, Ruttinger D, Wanner GA, Leiderer R, Menger MD. Modulation of kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock. 1996;6:434–441
  117. Weng Y-I, Shukla SD. Ethanol alters angiotensin II stimulated mitogen activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence. Eur J Pharmacol. 2000;398:323–331
  118. Weng Y-I, Shukla SD. Effects of chronic ethanol treatment on the angiotensin II–mediated p42/p44 mitogen-activated protein kinase and phosphorylase α activation in rat hepatocytes. Alcohol. 2003;29:83–90
  119. Yagami T, Kirita S, Matsushita A, Kawasaki K, Mizushima Y. Alterations in the stimulatory G protein of the rat liver after partial hepatectomy. Biochim Biophys Acta. 1994;1222:81–87
  120. Yamada Y, Weller RO, Kleihues P, Ludeke BI. Effects of ethanol and various alcoholic beverages on the formation of O6-methyldeoxyguanosine from concurrently administered N-nitrosomethylbenzylamine in rats: a dose-response study. Carcinogenesis. 1992;13:1171–1175
  121. Yang SQ, Lin HZ, Yin M, Albrecht JH, Diehl AM. Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol Gastrointest Liver Physiol. 1998;275:G696–G704
  122. Yang ZW, Xu GL. Isolated hepatic perfusion: a regional therapy for liver cancer. Hepatobiliary Pancreat Dis Int. 2004;3:12–16
  123. Yu H, Harris RE, Kabat GC, Wynder EL. Cigarette smoking, alcohol consumption and primary liver cancer: a case-control study in the USA. Int J Cancer. 1988;42:325–328
  124. Zern MA, Leo MA, Giambrone MA, Lieber CS. Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease. Gastroenterology. 1985;89:1123–1131
  125. Zhang JX, Bauer M, Clemens MG. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am J Physiol Gastrointest Liver Physiol. 1995;269:G269–G277
  126. Zhao J, Agarwal R. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis. 1999;20:2101–2108

PII: S0741-8329(05)00095-9

doi: 10.1016/j.alcohol.2005.04.004

Alcohol
Volume 35, Issue 3 , Pages 195-203 , April 2005

Article Tools